//--> //--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~person:"Scott Morton, Fiona"
~person:"Yesim Köksal, Miyase"
~subject:"1997-2002"
~subject:"Competition"
~subject:"pharmaceuticals"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"Pharmaceuticals"
Narrow search
Delete all filters
| 5 applied filters
Year of publication
From:
To:
Subject
All
1997-2002
Competition
pharmaceuticals
Pharmaceuticals
17
Arzneimittel
14
USA
9
United States
9
Preis
7
Price
7
Gesetzliche Krankenversicherung
6
Innovation
6
Public health insurance
6
Pharmaceutical industry
5
Pharmaindustrie
5
Gesundheitskosten
4
Health care costs
4
Health insurance
4
Krankenversicherung
4
innovation
4
Arzneimittelmarkt
3
EU enlargement
3
Elderly people
3
Pharmaceutical market
3
Preisregulierung
3
Price regulation
3
parallel trade
3
price competition
3
Ältere Menschen
3
2003-2006
2
Biologics
2
Demand
2
EU countries
2
EU-Staaten
2
Elasticity
2
Europa
2
Europe
2
Generic drugs
2
Generika
2
Gesundheitsreform
2
Gesundheitswesen
2
more ...
less ...
Online availability
All
Free
6
Undetermined
3
Type of publication
All
Book / Working Paper
7
Article
4
Type of publication (narrower categories)
All
Arbeitspapier
2
Article in journal
2
Aufsatz in Zeitschrift
2
Graue Literatur
2
Non-commercial literature
2
Working Paper
2
Aufsatz im Buch
1
Book section
1
more ...
less ...
Language
All
English
6
Undetermined
5
Author
All
Scott Morton, Fiona
Yesim Köksal, Miyase
Brekke, Kurt R.
15
Herr, Annika
15
Granlund, David
12
Suppliet, Moritz
12
Straume, Odd Rune
11
Dalen, Dag Morten
10
Duso, Tomaso
8
Kanavos, Panos
8
Birg, Laura
7
Berndt, Ernst R.
6
Dubois, Pierre
6
Holmås, Tor Helge
6
Wille, Eberhard
6
Danzon, Patricia Munch
5
Frank, Richard G.
5
Puig-Junoy, Jaume
5
Rudholm, Niklas
5
Sorisio, Enrico
5
Acharyya, Rajat
4
Bate, Roger
4
Böhler, Yvonne-Beatrice
4
Costa-i-Font, Joan
4
David, Guy
4
Garavaglia, Christian
4
Helble, Matthias
4
Kyle, Margaret K.
4
Lamping, Christian
4
Linnosmaa, Ismo
4
Malerba, Franco
4
Markowitz, Sara
4
Olivella, Pau
4
Orsenigo, Luigi
4
Pezzoni, Michele
4
Rizzo, John A.
4
Santiago-Rodriguez, Fernando
4
Stremersch, Stefan
4
Strøm, Steinar
4
Wichardt, Philipp C.
4
more ...
less ...
Institution
All
Nationalekonomiska institutionen, Handelshögskolan
2
C.E.P.R. Discussion Papers
1
Handelns Utredningsinstitut (HUI Research)
1
Institutionen för Nationalekonomi, Umeå Universitet
1
Published in...
All
Working Papers in Economics
2
CEPR Discussion Papers
1
HUI Working Papers
1
Handbook of health economics : volume 2
1
Handbook of health economics ; Volume two
1
Review of industrial organization : RIO
1
The quarterly journal of economics
1
Umeå Economic Studies
1
Working paper / National Bureau of Economic Research, Inc.
1
Working papers / Harvard Business School, Division of Research
1
more ...
less ...
Source
All
ECONIS (ZBW)
6
RePEc
5
Showing
1
-
10
of
11
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona
;
Stern, Ariel D.
;
Stern, Scott
-
2017
Persistent link: https://www.econbiz.de/10011708133
Saved in:
2
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona
;
Stern, Ariel D.
;
Stern, Scott
- In:
Review of industrial organization : RIO
53
(
2018
)
1
,
pp. 173-210
Persistent link: https://www.econbiz.de/10012009103
Saved in:
3
EU Enlargement, Parallel Trade and Price Competition in
Pharmaceuticals
- What’s to Blame? Derogation or Perception?
Granlund, David
;
Yesim Köksal, Miyase
-
Handelns Utredningsinstitut (HUI Research)
-
2012
Given the cost of trade and availability of
pharmaceuticals
, the driving force for parallel trade is the price … availability of
pharmaceuticals
for parallel trade should increase price competition in the destination country. Using 2003 …
Persistent link: https://www.econbiz.de/10010538874
Saved in:
4
Markets for pharmaceutical products
Scott Morton, Fiona
;
Kyle, Margaret K.
-
2012
Persistent link: https://www.econbiz.de/10011498384
Saved in:
5
Compassion and cost: The dual role of reference pricing
Yesim Köksal, Miyase
-
Nationalekonomiska institutionen, Handelshögskolan
-
2011
hazard. Focusing on
pharmaceuticals
consumption, this paper examines theoretically whether reference pricing, requiring …
Persistent link: https://www.econbiz.de/10011019119
Saved in:
6
EU Enlargement, Parallel Trade and Price Competition in
Pharmaceuticals
- What’s to Blame? Derogation or Perception?
Granlund, David
;
Yesim Köksal, Miyase
-
Institutionen för Nationalekonomi, Umeå Universitet
-
2011
Given the cost of trade and availability of
pharmaceuticals
, the driving force for parallel trade is the price … availability of
pharmaceuticals
for parallel trade should increase price competition in the destination country. Using 2003 …
Persistent link: https://www.econbiz.de/10009294753
Saved in:
7
EU Enlargement, Parallel Trade and Price Competition in
Pharmaceuticals
. What's blame? Derogation or perception?
Granlund, David
;
Yesim Köksal, Miyase
-
Nationalekonomiska institutionen, Handelshögskolan
-
2011
Given the cost of trade and availability of
pharmaceuticals
, the driving force for parallel trade is the price … availability of
pharmaceuticals
for parallel trade should increase price competition in the destination country. Using 2003 …
Persistent link: https://www.econbiz.de/10010818749
Saved in:
8
Chapter Twelve. Markets for Pharmaceutical Products
Scott Morton, Fiona
;
Kyle, Margaret
- In:
Handbook of health economics : volume 2
,
(pp. 763-823)
.
2011
This chapter describes the market for
pharmaceuticals
, which exceeded $500 million in sales in 2010. The industry is …
Persistent link: https://www.econbiz.de/10014025576
Saved in:
9
The distortionary effects of government procurement : evidence from Medicaid prescription drug purchasing
Duggan, Mark G.
;
Scott Morton, Fiona
-
2004
Persistent link: https://www.econbiz.de/10002469626
Saved in:
10
Market Size and Pharmaceutical Innovation
de Mouzon, Oliver
;
Dubois, Pierre
;
Scott Morton, Fiona
; …
-
C.E.P.R. Discussion Papers
-
2011
the hypothesis that innovation in
pharmaceuticals
is becoming more difficult and expensive over time, as costs of …
Persistent link: https://www.econbiz.de/10009003149
Saved in:
1
2
Next
Last
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->